secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adagio Medical Holdings, Inc. (ADGM)
CIK:        0002006986
Form:       8-K
Filed at:   2024-12-16T23:59:59+00:00
Accession:  0001558370-24-016265
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adagio Medical appoints Todd Usen as CEO; founder Olav Bergheim departs as CEO and Chairman
--------------------------------------------------------------------------------

- Olav Bergheim resigns as CEO and Chairman effective Dec 13, 2024; receives severance of $1.2M cash plus contingent $300K.
- Bergheim will serve as advisor for 12 months and receives an option for 338,398 shares of common stock.
- Todd Usen appointed CEO and Director effective Dec 13, 2024; base salary $500K/year, bonus up to 50%, and option for ~5% fully diluted shares.
- Orly Mishan appointed Chairperson of the Board effective Dec 13, 2024.
- Bergheim's departure not due to disagreement with financial reporting or operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2006986/000155837024016265/0001558370-24-016265-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2006986/000155837024016265/adgm-20241211x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-016265

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer